-
Shift Toward Chemotherapy-Free Approaches Redefines Upfront CLL Treatment Selection
07 Aug 2025 02:41 GMT
As upfront treatment approaches in chronic lymphocytic leukemia (CLL) become increasingly less reliant … Dorritie also highlighted differences in treatment strategies for patients with newly … in untreated chronic lymphocytic leukemia. N Engl J Med. 2025;392(8 …
-
Leukemia-Stromal Cell Co-Culture Platform Developed
06 Aug 2025 23:24 GMT
… allows for precise interrogation of drug responses within a physiologically relevant … on leukemia cells alone but also assess how niche elements modulate drug … for more effective and durable leukemia treatments by bridging the marrow like …
-
Aptose Enrollment is Open for 160 mg Dosing Cohort of Tuspetinib in Phase 1/2 TUSCANY Trial of Frontline Triple Drug Therapy
06 Aug 2025 20:30 GMT
… Loan Agreement with Hanmi Pharmaceutical
SAN DIEGO and TORONTO, … (TUS)-based triple drug frontline therapy to treat … relapsed or refractory acute myeloid leukemia (AML) and is … risks in early stage drug development including demonstrating efficacy; …
-
Degradation of LMO2 in T cell leukaemia results in collateral breakdown of transcription complex partners and causes LMO2-dependent apoptosis
06 Aug 2025 17:47 GMT
… context of T cell acute leukaemia, we have produced two … are lead compounds for drug development for LMO2-positive … changes following Abd-VHL treatment compared to control treatment (DMSO) in … cancer (36). In acute myeloid leukemia (AML) cells, the LMO2…
-
Many patients with high-risk myelodysplastic syndromes do not receive guideline-recommended treatment
06 Aug 2025 17:15 GMT
… medications became available.
The study is the largest analysis of MDS treatment … Without treatment, MDS can progress to acute myeloid leukemia. MDS … U.S. Food and Drug Administration approved two HMAs … HMAs and whether the drugs were being administered …
-
Global Myeloproliferative Disorder Treatment Market is Expected to Showcase an Incremental Growth at a CAGR of ~5% by 2032 | DelveInsight
06 Aug 2025 17:00 GMT
… Therapies may include medications like hydroxyurea or … myelofibrosis or acute leukemia, may require targeted … Teva Pharmaceuticals, Merck, and others
Myeloproliferative Disorder Treatment Market … trends, in emerging drugs, and competitive strategies. …
-
Jimmy Fund campaign features Natick child’s fight against leukemia
06 Aug 2025 13:12 GMT
… was diagnosed with acute lymphoblastic leukemia in April 2024, just two … all patients receive the critical treatment and support they need at …
-
Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment
06 Aug 2025 12:40 GMT
… with cytarabine for the treatment of AML; Anticipated … stage pharmaceutical company with a broad portfolio of drug … the treatment of relapsed or refractory acute myeloid leukemia (AML … the treatment of relapsed or refractory acute myeloid leukemia. Following …
-
New Drug May Fight a Deadly Bone Marrow Disorder
06 Aug 2025 12:14 GMT
… 2025 — A recently approved leukemia pill also might help some patients … treatment with olutasidenib (Rezlidhia), which the U.S. Food and Drug … noted.
“Both are exceptional drugs,” said Watts.
The results … led to changes in treatment standards, researchers said. …
-
Acute and chronic Leukemia (Blood cancer): Differences and 5 early signs
06 Aug 2025 11:56 GMT
… quot;Acute vs. chronic leukemia: Symptoms, causes, treatment"
Rocky Mountain Cancer … Centers: "Early Symptoms of Leukemia… “Acute lymphocytic leukemia - Symptoms”, “Chronic lymphocytic leukemia - Symptoms”
…
About
© 1995-2025